Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.235
+0.085 (2.70%)
Jan 23, 2025, 12:11 PM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $110.33 million as of January 23, 2025. Its market cap has decreased by -70.29% in one year.
Market Cap
110.33M
Enterprise Value
75.41M
1-Year Change
-70.29%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $110.33M, a decrease of -22.13%. That is a compound annual growth rate of -11.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 107.43M | 33.47% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.17B |
| UnitedHealth Group | 477.50B |
| Novo Nordisk | 355.54B |
| Johnson & Johnson | 346.00B |
| AbbVie | 298.35B |
| Merck & Co. | 243.02B |
| Thermo Fisher Scientific | 221.21B |
| Intuitive Surgical | 218.61B |